Medication info
Expain ER Extended-Release Tablet

Expain ER Extended-Release Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›75mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
HanDoc Co., Ltd.
Appearance
Pale yellow rectangular film-coated extended-release tablet
Packaging
30 tablets, 100 tablets/bottle
Approval status
Active

MFDS item code 201207591 · Approved 2012.10.31 · Insurance code 652105220

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and treatment response. An initial dose of 1 tablet is recommended. Thereafter, doses should be taken at intervals of at least 12 hours, and the dose should not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should continue. Nausea, vomiting, itching, constipation, dizziness, drowsiness, etc. may occur when taking this medicine; therefore, monitor the patient's response closely and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to older adults aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
HanDoc Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate acute pain
  • severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and treatment response. An initial dose of 1 tablet is recommended. Thereafter, doses should be taken at intervals of at least 12 hours, and the dose should not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should continue. Nausea, vomiting, itching, constipation, dizziness, drowsiness, etc. may occur when taking this medicine; therefore, monitor the patient's response closely and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to older adults aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Precautions

This medication should be consulted with a doctor or pharmacist before use by individuals who regularly consume more than three alcoholic beverages a day, as this can lead to liver damage. This medication can rarely cause serious skin reactions, and if skin rash or hypersensitivity occurs, discontinue use immediately. The tramadol component in this medication may increase the risk of seizures; caution is required when used by individuals with a history of seizures or alongside other medications that may induce seizures. Rarely, life-threatening anaphylaxis reactions may occur in patients taking this medication, so be cautious of allergic symptoms. When administered to patients with acute and severe bronchial asthma, there is a high risk of respiratory depression. It should be administered only in settings with adequate medical equipment. Taking this medication with alcohol or benzodiazepines can increase the risk of severe sedation, respiratory depression, coma, and death, so concurrent use should be avoided. Patients with increased intracranial pressure or head injuries should use this medication with caution, as symptoms may worsen due to respiratory depression. Tramadol can lead to both psychological and physical dependence, so the risk of dependence should be considered with prolonged use. The acetaminophen ingredient in this medication can burden the liver, so those with liver dysfunction or who are using other acetaminophen products should be cautious. Particularly, ultra-rapid metabolizers of CYP2D6 may rapidly metabolize this medication's components, increasing the risk of respiratory depression; therefore, dose adjustment and monitoring are necessary. This medication should not be administered to children under 12 years old or adolescents under 18 years old who have undergone tonsillectomy and adenoidectomy, and it should be avoided in patients aged 12 to 18 years with specific risks. Hyponatremia may occur during treatment with this medication, so elderly patients or those with risk factors should be monitored closely for symptoms. This medication is contraindicated in individuals with hypersensitivity to its components, severe respiratory depression, central nervous system drug intoxication, severe liver, kidney, or heart dysfunction, breastfeeding mothers, and certain pediatric patients. Drowsiness or dizziness may occur during treatment, which requires caution when driving or operating machinery. In case of overdose, severe respiratory depression and liver damage may occur, so it is important to adhere to the recommended dosage, and in case of overdose, contact a medical institution immediately. This medication can interact with multiple drugs, and it is essential to consult a doctor or pharmacist when taking other medications. Pregnant or breastfeeding women should consult healthcare professionals before taking this medication, especially breastfeeding mothers should be attentive to adverse reactions in breastfed infants. Elderly patients need careful observation when using this medication due to the potential decline in liver, kidney, and heart function.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, stiffness, syncope, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremor, ataxia, convulsions, hypertonia, migraine, worsening migraine, involuntary muscle contractions, paresthesia, confusion, vertigo, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, blood in stool, tongue swelling, decreased appetite, anxiety, delirium, euphoria, insomnia, nervousness, drowsiness, forgetfulness, depersonalization, depression, substance abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urination disorder, oliguria, urinary retention, pruritus, rash, sweating, urticaria, liver function abnormality, weight loss, tinnitus, abnormal vision, chills, vascular relaxation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reaction, anaphylaxis, appetite changes, exercise weakness, respiratory suppression, cognitive dysfunction, concentration difficulties, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, delirium, miosis, mydriasis, speech disorder, motor disorder, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, high anion gap metabolic acidosis, weakness, fever, edema, stiffness, syncope, congestive heart failure, dizziness, confusion, ataxia, hematuria, dark urine, anuria, urinary retention, urinary incontinence, upper abdominal pain, peptic ulcer, belching, peripheral edema, pallor, blood pressure fluctuations, cough, runny nose, hypertension, palpitations, irregular menstruation, breast cancer, injury, hematemesis, cholesterol increase, hip pain, thigh pain, allergic rhinitis, epistaxis, cholecystitis, cholecystitis, paralytic ileus, renal function abnormality, increased salivation, hiccups, drowsiness, insomnia, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, palpitations, hypertension, arrhythmia, tachycardia, worsening hypertension, aortic stenosis, nausea, vomiting, dyspepsia, abdominal pain, constipation, dry mouth, diarrhea, dysphagia, flatulence, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, decreased appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, dyspnea, asthma, exertional dyspnea, cough, bronchitis, urination disorder, urinary retention, polyuria, renal function abnormality, oliguria, pruritus, rash, increased sweating, urticaria, nausea, constipation, vomiting, urticaria, headache, dyspepsia, cold sweat, decreased appetite, dizziness, drowsiness, thirst, dry mouth, hyperhidrosis, rash, urination disorder, abdominal pain, insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated extended-release tablet

Package unit

30 tablets, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.